Anchor Capital Advisors LLC reduced its holdings in shares of Watsco, Inc. (NYSE:WSO – Free Report) by 6.0% during the fourth quarter, HoldingsChannel.com reports. The fund owned 165,177 shares of the construction company’s stock after selling 10,579 shares during the quarter. Watsco makes up approximately 1.9% of Anchor Capital Advisors LLC’s investment portfolio, making the […]
SRS Capital Advisors Inc. lifted its position in AutoZone, Inc. (NYSE:AZO – Free Report) by 49.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 155 shares of the company’s stock after purchasing an additional 51 shares during the quarter. SRS Capital Advisors […]
Anchor Capital Advisors LLC trimmed its stake in shares of Lowe’s Companies, Inc. (NYSE:LOW – Free Report) by 2.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 78,280 shares of the home improvement retailer’s stock after selling 1,866 shares during the quarter. Anchor Capital […]
Anchor Capital Advisors LLC trimmed its holdings in shares of Americold Realty Trust, Inc. (NYSE:COLD – Free Report) by 6.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,153,775 shares of the company’s stock after selling 73,044 shares during the quarter. Anchor Capital […]
SRS Capital Advisors Inc. bought a new position in shares of Fiserv, Inc. (NYSE:FI – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 8,325 shares of the business services provider’s stock, valued at approximately $1,106,000. A […]
Guyasuta Investment Advisors Inc. trimmed its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.9% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 31,256 shares of the company’s stock after selling 1,255 shares during the quarter. Guyasuta Investment Advisors Inc.’s holdings in AbbVie were worth […]
Anchor Capital Advisors LLC decreased its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 1.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 107,216 shares of the company’s stock after selling 1,673 shares during the quarter. Anchor Capital Advisors LLC’s holdings […]
Abbrea Capital LLC reduced its holdings in shares of AT&T Inc. (NYSE:T – Free Report) by 22.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,464 shares of the technology company’s stock after selling 6,570 shares during the quarter. Abbrea Capital LLC’s […]
Anchor Capital Advisors LLC cut its position in shares of Shell plc (NYSE:SHEL – Free Report) by 2.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 317,386 shares of the energy company’s stock after selling 6,637 shares during the […]
Anchor Capital Advisors LLC trimmed its position in Analog Devices, Inc. (NASDAQ:ADI – Free Report) by 5.1% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 364,177 shares of the semiconductor company’s stock after selling 19,631 shares during the period. Analog Devices accounts for about 1.9% of […]
Abbrea Capital LLC boosted its stake in shares of Waste Management, Inc. (NYSE:WM – Free Report) by 3.6% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,588 shares of the business services provider’s stock after purchasing an additional 90 shares during the period. Abbrea Capital LLC’s […]
Syon Capital LLC boosted its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 111.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 64,444 shares of the biopharmaceutical company’s stock after purchasing an additional 33,961 shares during […]